糖尿病患者肌少症的患病率及危险因素:一项Meta分析
该Meta分析检索截至2020年11月30日的多个数据库,纳入年龄≥18岁临床诊断糖尿病患者的有关研究,发现糖尿病患者肌少症合并患病率为18%(95%CI 16-20),男性高于女性,亚洲高于南美洲和大洋洲;年龄、HbA1c、内脏脂肪面积、糖尿病肾病、糖尿病病程和高敏C反应蛋白是可能危险因素。
要点
- 糖尿病患者肌少症合并患病率为18%(95%CI 16-20)。
- 男性肌少症患病率高于女性,亚洲高于南美洲和大洋洲。
- 年龄、HbA1c、内脏脂肪面积、糖尿病肾病、糖尿病病程和hs-CRP为可能危险因素。
核心结论
- 糖尿病患者中肌少症较为常见,年龄、HbA1c、内脏脂肪面积、糖尿病肾病、糖尿病病程和高敏C反应蛋白是可能危险因素。
研究设计与样本
- 检索PubMed、Embase、Web of Science、万方、CNKI、维普和CBM数据库截至2020年11月30日发表的相关研究,纳入年龄≥18岁临床诊断糖尿病患者,不限制性别和糖尿病类型,由2名评价者独立使用标准数据采集表提取数据。
主要发现
- 糖尿病患者肌少症合并患病率为18%(95%CI 16-20)。
- 亚组分析显示男性肌少症患病率高于女性,亚洲患病率高于南美洲和大洋洲。
- 年龄(OR 1.10)、HbA1c(OR 1.16)、内脏脂肪面积(OR 1.03)、糖尿病肾病(OR 2.54)、糖尿病病程(OR 1.06)和高敏C反应蛋白(OR 1.33)是糖尿病患者肌少症的危险因素。
临床怎么用
- 作者认为,未来医务人员不仅应关注高危人群肌少症的早期筛查,还应提供预防相关信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The prevalence of sarcopenia in patients with diabetes is 3 times higher than that in patients without diabetes and is associated with a poor prognosis. OBJECTIVE: To investigate the global pooled prevalence and risk factors of sarcopenia in patients with diabetes. DATA SOURCES: Relevant studies published until November 30, 2020, were identified from the PubMed, Embase, Web of Science, WanFang, CNKI, VIP, and CBM databases. STUDY SELECTION: Participants with age ≥ 18 years with clinically diagnosed diabetes. Sex and diabetes type were not restricted. DATA EXTRACTION: The data were extracted by 2 reviewers independently using a standard data collection form. DATA SYNTHESIS: The pooled prevalence of sarcopenia in patients with diabetes was 18% (95% CI, 16-20); subgroup analysis showed that sarcopenia was more prevalent in males than in females, as well as being more prevalent in Asia than in South America and Oceania. Age (odds ratio [OR], 1.10), glycated hemoglobin (HbA1c) (OR = 1.16), visceral fat area (VFA) (OR = 1.03), diabetic nephropathy (OR = 2.54), duration of diabetes (OR = 1.06), and high-sensitivity C-reactive protein (hs-CRP) (OR = 1.33) were risk factors for sarcopenia in patients with diabetes. CONCLUSIONS: Sarcopenia was more prevalent in patients with diabetes. Age, HbA1c, VFA, diabetic nephropathy, duration of diabetes, and hs-CRP were the probable risk factors. In the future, medical staff should not only pay attention to the early screening of sarcopenia in high-risk groups, but also provide information on its prevention.
引用
- Feng L, Gao Q, Hu K, et al. Prevalence and Risk Factors of Sarcopenia in Patients With Diabetes: A Meta-analysis. J Clin Endocrinol Metab. 2022. PMID: 34904651. doi:10.1210/clinem/dgab884
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。